Cargando…

Analysis of Prescriptions of Alpha-Blockers and Phosphodiesterase 5 Inhibitors from the Urology Department and Other Departments

PURPOSE: We analyzed the prescriptions of alpha-blockers and phosphodiesterase 5 inhibitors (PDE5Is) in the urology department as well as in other departments of the general hospital. METHODS: We investigated the frequency of prescription of alpha-blockers and PDE5Is from 3 general hospitals from Ja...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Dong Hyuk, Lee, Joo Yong, Chung, Jae Hoon, Cho, Hee Ju, Cho, Jeong Man, Moon, Hong Sang, Kim, Yong Tae, Yoo, Tag Keun, Choi, Hong Yong, Park, Hae Young, Lee, Seung Wook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Continence Society 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3256307/
https://www.ncbi.nlm.nih.gov/pubmed/22259736
http://dx.doi.org/10.5213/inj.2011.15.4.216
_version_ 1782221066085597184
author Kang, Dong Hyuk
Lee, Joo Yong
Chung, Jae Hoon
Cho, Hee Ju
Cho, Jeong Man
Moon, Hong Sang
Kim, Yong Tae
Yoo, Tag Keun
Choi, Hong Yong
Park, Hae Young
Lee, Seung Wook
author_facet Kang, Dong Hyuk
Lee, Joo Yong
Chung, Jae Hoon
Cho, Hee Ju
Cho, Jeong Man
Moon, Hong Sang
Kim, Yong Tae
Yoo, Tag Keun
Choi, Hong Yong
Park, Hae Young
Lee, Seung Wook
author_sort Kang, Dong Hyuk
collection PubMed
description PURPOSE: We analyzed the prescriptions of alpha-blockers and phosphodiesterase 5 inhibitors (PDE5Is) in the urology department as well as in other departments of the general hospital. METHODS: We investigated the frequency of prescription of alpha-blockers and PDE5Is from 3 general hospitals from January 1, 2007 to December 31, 2009. For alpha-blockers, data were collected from patients to whom alpha-blockers were prescribed from among patients recorded as having benign prostatic hyperplasia according to the 5th Korean Standard Classification of Diseases. For PDE5Is, data were collected from patients to whom PDE5Is were prescribed by the urology department and by other departments. Alpha-blockers were classified into tamsulosin, alfuzosin, doxazosin, and terazosin, whereas PDE5Is were classified into sildenafil, tadalafil, vardenafil, udenafil, and mirodenafil. RESULTS: Alpha-blockers were prescribed to 11,436 patients in total over 3 years, and the total frequency of prescriptions was 68,565. Among other departments, the nephrology department had the highest frequency of prescription of 3,225 (4.7%), followed by the cardiology (3,101, 4.5%), neurology (2,576, 3.8%), endocrinology (2,400, 3.5%), pulmonology (1,102, 1.6%), and family medicine (915, 1.3%) departments in order. PDE5Is were prescribed to 2,854 patients in total over 3 years, and the total frequency of prescriptions was 10,558. The prescription frequency from the urology department was 4,900 (46.4%). Among other departments, the endocrinology department showed the highest prescription frequency of 3,488 (33.0%), followed by the neurology (542, 5.1%), cardiology (467, 4.4%), and family medicine (407, 3.9%) departments in order. CONCLUSIONS: A high percentage of prescriptions of alpha-blockers and PDE5Is were from other departments. For more specialized medical care by urologists is required in the treatment of lower urinary tract symptoms and erectile dysfunction.
format Online
Article
Text
id pubmed-3256307
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Korean Continence Society
record_format MEDLINE/PubMed
spelling pubmed-32563072012-01-18 Analysis of Prescriptions of Alpha-Blockers and Phosphodiesterase 5 Inhibitors from the Urology Department and Other Departments Kang, Dong Hyuk Lee, Joo Yong Chung, Jae Hoon Cho, Hee Ju Cho, Jeong Man Moon, Hong Sang Kim, Yong Tae Yoo, Tag Keun Choi, Hong Yong Park, Hae Young Lee, Seung Wook Int Neurourol J Original Article PURPOSE: We analyzed the prescriptions of alpha-blockers and phosphodiesterase 5 inhibitors (PDE5Is) in the urology department as well as in other departments of the general hospital. METHODS: We investigated the frequency of prescription of alpha-blockers and PDE5Is from 3 general hospitals from January 1, 2007 to December 31, 2009. For alpha-blockers, data were collected from patients to whom alpha-blockers were prescribed from among patients recorded as having benign prostatic hyperplasia according to the 5th Korean Standard Classification of Diseases. For PDE5Is, data were collected from patients to whom PDE5Is were prescribed by the urology department and by other departments. Alpha-blockers were classified into tamsulosin, alfuzosin, doxazosin, and terazosin, whereas PDE5Is were classified into sildenafil, tadalafil, vardenafil, udenafil, and mirodenafil. RESULTS: Alpha-blockers were prescribed to 11,436 patients in total over 3 years, and the total frequency of prescriptions was 68,565. Among other departments, the nephrology department had the highest frequency of prescription of 3,225 (4.7%), followed by the cardiology (3,101, 4.5%), neurology (2,576, 3.8%), endocrinology (2,400, 3.5%), pulmonology (1,102, 1.6%), and family medicine (915, 1.3%) departments in order. PDE5Is were prescribed to 2,854 patients in total over 3 years, and the total frequency of prescriptions was 10,558. The prescription frequency from the urology department was 4,900 (46.4%). Among other departments, the endocrinology department showed the highest prescription frequency of 3,488 (33.0%), followed by the neurology (542, 5.1%), cardiology (467, 4.4%), and family medicine (407, 3.9%) departments in order. CONCLUSIONS: A high percentage of prescriptions of alpha-blockers and PDE5Is were from other departments. For more specialized medical care by urologists is required in the treatment of lower urinary tract symptoms and erectile dysfunction. Korean Continence Society 2011-12 2011-12-31 /pmc/articles/PMC3256307/ /pubmed/22259736 http://dx.doi.org/10.5213/inj.2011.15.4.216 Text en Copyright © 2011 Korean Continence Society http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/ (http://creativecommons.org/licenses/by-nc/3.0) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Kang, Dong Hyuk
Lee, Joo Yong
Chung, Jae Hoon
Cho, Hee Ju
Cho, Jeong Man
Moon, Hong Sang
Kim, Yong Tae
Yoo, Tag Keun
Choi, Hong Yong
Park, Hae Young
Lee, Seung Wook
Analysis of Prescriptions of Alpha-Blockers and Phosphodiesterase 5 Inhibitors from the Urology Department and Other Departments
title Analysis of Prescriptions of Alpha-Blockers and Phosphodiesterase 5 Inhibitors from the Urology Department and Other Departments
title_full Analysis of Prescriptions of Alpha-Blockers and Phosphodiesterase 5 Inhibitors from the Urology Department and Other Departments
title_fullStr Analysis of Prescriptions of Alpha-Blockers and Phosphodiesterase 5 Inhibitors from the Urology Department and Other Departments
title_full_unstemmed Analysis of Prescriptions of Alpha-Blockers and Phosphodiesterase 5 Inhibitors from the Urology Department and Other Departments
title_short Analysis of Prescriptions of Alpha-Blockers and Phosphodiesterase 5 Inhibitors from the Urology Department and Other Departments
title_sort analysis of prescriptions of alpha-blockers and phosphodiesterase 5 inhibitors from the urology department and other departments
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3256307/
https://www.ncbi.nlm.nih.gov/pubmed/22259736
http://dx.doi.org/10.5213/inj.2011.15.4.216
work_keys_str_mv AT kangdonghyuk analysisofprescriptionsofalphablockersandphosphodiesterase5inhibitorsfromtheurologydepartmentandotherdepartments
AT leejooyong analysisofprescriptionsofalphablockersandphosphodiesterase5inhibitorsfromtheurologydepartmentandotherdepartments
AT chungjaehoon analysisofprescriptionsofalphablockersandphosphodiesterase5inhibitorsfromtheurologydepartmentandotherdepartments
AT choheeju analysisofprescriptionsofalphablockersandphosphodiesterase5inhibitorsfromtheurologydepartmentandotherdepartments
AT chojeongman analysisofprescriptionsofalphablockersandphosphodiesterase5inhibitorsfromtheurologydepartmentandotherdepartments
AT moonhongsang analysisofprescriptionsofalphablockersandphosphodiesterase5inhibitorsfromtheurologydepartmentandotherdepartments
AT kimyongtae analysisofprescriptionsofalphablockersandphosphodiesterase5inhibitorsfromtheurologydepartmentandotherdepartments
AT yootagkeun analysisofprescriptionsofalphablockersandphosphodiesterase5inhibitorsfromtheurologydepartmentandotherdepartments
AT choihongyong analysisofprescriptionsofalphablockersandphosphodiesterase5inhibitorsfromtheurologydepartmentandotherdepartments
AT parkhaeyoung analysisofprescriptionsofalphablockersandphosphodiesterase5inhibitorsfromtheurologydepartmentandotherdepartments
AT leeseungwook analysisofprescriptionsofalphablockersandphosphodiesterase5inhibitorsfromtheurologydepartmentandotherdepartments